Iptycene-DeriVed Pyridazines and Phthalazines
hexanes:ethyl acetate (v/v) to afford 22 as a white solid (3.09 g,
91%). Mp 213-215 °C; H NMR (500 MHz, CDCl3) δ 7.72-
2.0 mmol) and solid NaOMe (125 mg, 2.3 mmol) were placed in
a Schlenk flask, and the contents were evacuated and back-filled
with argon five times. Dry THF (∼50 mL) was added and the
resulting mixture was stirred at room temperature for 2 days.
Solvents were then evaporated under reduced pressure and the
residue was purified by chromatography on SiO2 with use of 10:
4:1 hexanes:dichloromethane:ethyl acetate (v/v/v) as the mobile
phase to yield first unreacted starting material 33a (0.48 g recovery),
followed by the desired chloro methoxy dimer 34 as a white solid
(0.32 g, 28% or 47% based on recovered starting material) and
finally the dimethoxy dimer 31a (0.10 g). Mp 318 °C dec; 1H NMR
(500 MHz, CDCl3) δ 7.59-7.57 (d, 2H, J ) 7.0 Hz), 7.54-7.53
(d, 2H, J ) 7.0 Hz), 7.51-7.50 (d, 2H, J ) 7.0 Hz), 7.45-7.44
(d, 2H, J ) 7.0 Hz), 7.14-7.02 (m, 8H), 6.40 (s, 1H), 6.23 (s,
1H), 6.01 (s, 1H), 5.96 (s, 1H), 4.36 (s, 3H); 13C NMR (125 MHz,
CDCl3) δ 160.8, 152.7, 151.9, 149.8, 149.3, 148.8, 146.3, 143.9,
143.5, 143.1, 142.5, 136.5, 126.5, 126.2, 126.0, 125.8, 125.7, 125.4,
124.8, 124.5, 55.5, 50.3, 50.2. 50.0, 46.7; HR-MS (ESI) calcd for
C37H23 ClN4O [M + H]+ 575.1633, found 575.1613.
1
7.70 (d, 2H, J ) 7.0 Hz), 7.63-7.60 (t, 2H, J ) 7.3 Hz), 7.58-
7.56 (d, 1H, J ) 7.0 Hz), 7.53-7.52 (d, 2H, J ) 6.5 Hz), 7.42-
7.40 (d, 2H, J ) 6.0 Hz), 7.10-7.04 (m, 4H), 5.90 (s, 1H), 5.81
(s, 1H), 4.20 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 160.1, 153.8,
147.1, 143.85, 143.79, 136.6, 135.2, 129.4, 129.0, 128.9, 126.0,
125.9, 124.8, 124.5, 55.1, 50.4, 46.8; IR (KBr) 3043, 2945, 1570,
1458, 1315, 1265, 736; HR-MS (ESI) calcd for C25H18N2O [M +
H]+ 363.1492, found 363.1485.
Typical Procedures for the Preparation of Dimers and Higher
Oligomers by Reductive Coupling (“a” series): (a) 1,1′-Bi(9,-
10-dihydro-4-methoxy-9,10-[1′′,2′′]benzeno-2,3-diazaanthrace-
nyl) (31a). In a septum-capped Schlenk flask are placed the
methoxy chloride 6a (7.50 g, 23 mmol), activated zinc dust (9.1 g,
140 mmol), trans-dichlorobis(triphenylphosphine)palladium(II) (820
mg, 1.2 mmol), and triphenylphosphine (612 mg, 2.3 mmol). The
flask is evacuated and back-filled with argon five times, and dry
dimethylformamide (ca. 90 mL) is added. The resulting mixture is
stirred at 100 °C for ca. 20 h, after which TLC indicates complete
consumption of the starting material. The reaction mixture is then
poured into a large excess of aq Na2EDTA and triturated for a few
hours. Filtration of the precipitates yields a crude product that is
purified by column chromatography on silica gel with use of 10:
4:1 hexanes:dichloromethane:ethyl acetate (v/v/v) as the mobile
phase, to yield the pure 31a as a white solid (6.34 g, 95%). Mp
(e) 1,1′-Bi(6,11-dihydro-4-methoxy-6,11-[1′′,2′′]benzeno-2,3-
diazatetracenyl) (35). In a septum-capped Schlenk flask are placed
the methoxy chloride 14a (185 mg, 0.5 mmol), activated zinc dust
(195 mg, 3.0 mmol), trans-dichlorobis(triphenylphosphine)palladium-
(II) (35 mg, 0.05 mmol), and triphenylphosphine (26 mg, 0.10
mmol). The flask is evacuated and back-filled with argon five times,
and dry dimethylformamide (3 mL) is then added. The resulting
mixture is stirred at 100 °C for ca. 20 h, after which TLC indicates
complete consumption of the starting material. The reaction mixture
is poured into a large excess of aq Na2EDTA and triturated for a
few hours. Filtration of the precipitates yields a crude product that
is purified by column chromatography on silica gel with use of
5:1 dichloromethane:ethyl acetate (v/v) as the mobile phase, yielding
the pure dimer 35 as a white solid (37 mg, 17%). Mp >310 °C
1
>330 °C; H NMR (500 MHz, CDCl3) δ 7.52-7.50 (d, 4H, J )
7 Hz), 7.41-7.40 (d, 4H, J ) 7 Hz), 7.07-6.99 (m, 8H), 6.14 (s,
2H), 5.93 (s, 2H), 4.36 (s, 6H); 13C NMR (125 MHz, CDCl3) δ
160.6, 150.2, 149.4, 144.2, 143.7, 136.2, 126.0, 125.7, 125.4, 124.4,
55.4, 50.2, 46.8; IR (KBr) 3044, 2949, 1568, 1457, 1347, 1263,
729; HR-MS (ESI) calcd for C38H26N4O2 [M + H]+ 571.2129,
found 571.2122.
1
dec; H NMR (500 MHz, CDCl3) δ 8.29 (s, 2H), 7.82 (s, 2H),
(b) 1,1′-Bi(9,10-dihydro-9,10-[1′′,2′′]benzeno-2,3-diazaanthra-
cenyl)-4,4′(3H,3′H)-dione (32a). Dimethoxy dimer 31a (6.00 g,
10.5 mmol) was added to a stirred solution of hydrogen bromide
in acetic acid (33% by wt, 60 mL) and the mixture was heated to
90 °C overnight. Upon warming dissolution occurs and a violent
gas release is observed. The mixture is then cooled and most of
the solvent is evaporated under reduced pressure. The resulting solid
is suspended and triturated for several hours in a solution of sodium
acetate (ca. 25 g in 200 mL of H2O). Filtration affords 32a as a
pale beige solid (5.20 g, 91%). Mp >330 °C; 1H NMR (500 MHz,
(CD3)2SO) δ 13.59 (s, 2H), 7.56-7.55 (d, 4H, J ) 7 Hz), 7.39-
7.38 (d, 4H, J ) 7 Hz), 7.00-6.99 (m, 8H), 6.03 (s, 2H), 5.98 (s,
2H); 13C NMR (125 MHz, (CD3)2SO) δ 158.3, 150.4, 146.3, 143.9,
143.7, 138.4, 125.4, 125.3, 124.8, 124.2, 49.7, 46.4; HR-MS (ESI)
calcd for C36H22N4O2 [M + H]+ 543.1816, found 543.1838.
(c) 1,1′-Bi(4-chloro-9,10-dihydro-9,10-[1′′,2′′]benzeno-2,3-di-
azaanthracenyl) (33a). The deprotected dimer 32a (4.00 g, 74
mmol) was stirred overnight at 90 °C in ca. 80 mL of neat POCl3.
The mixture was cooled, and the excess POCl3 was evaporated
under reduced pressure. The brown gummy residue was redissolved
in PhMe (ca. 50 mL) and evaporated again under reduced pressure
to eliminate more of the residual POCl3. The residue was then
dissolved in CH2Cl2 (ca. 80 mL), triturated with neutral alumina
for 1 h, filtered through a neutral alumina plug, and eluted first
with CH2Cl2, then with EtOAc. Evaporation of the solvents under
reduced pressure, followed by purification by chromatography on
SiO2 with use of 10:4:1 hexanes:dichloromethane:ethyl acetate (v/
v/v) as the mobile phase yields the pure 33a as a white solid (2.84
g, 66%). Mp >330 °C; 1H NMR (500 MHz, CDCl3) δ 7.58-7.56
(d, 4H, 7 Hz), 7.49-7.48 (d, 4H, 7 Hz), 7.13-7.06 (m, 8H), 6.37
(s, 2H), 5.99 (s, 2H); 13C NMR (75 MHz, CDCl3) δ 152.4, 151.8,
149.2, 146.6, 142.9, 142.4, 126.6, 126.4, 125.7, 124.9, 50.20, 50.17;
IR (KBr) 3044, 2988, 1531, 1459, 1287, 1194, 705; HR-MS (ESI)
calcd for C36H20Cl2N4 [M + H]+ 579.1138, found 579.1117.
(d) 6-Chloro-4,4′,5,5′-bis(9,10-dihydroanthracen-9,10-diyl)-
6′-methoxy-3,3′-bipyridazine (34). Dichloro dimer 33a (1.16 g,
7.44-7.42 (d, 4H, J ) 6.5 Hz), 7.32-7.31 (d, 4H, J ) 7.0 Hz),
7.05-6.97 (m, 8H), 5.67 (s, 2H), 5.45 (s, 2H), 4.38 (s, 6H); 13C
NMR (125 MHz, CDCl3) δ 161.0, 152.4, 149.3, 149.1, 143.58,
143.55, 127.6, 126.04, 126.03, 124.5, 124.1, 120.4, 118.8, 117.1,
55.3, 54.2, 53.9; HR-MS (ESI) calcd for C46H30N4O2 [M + H]+
671.2442, found 671.2446.
(f) Quaterpyridazine (37). In a septum-capped Schlenk flask
are placed the chloro methoxy dimer 34 (115 mg, 0.20 mmol),
activated zinc dust (78 mg, 1.2 mmol), trans-dichlorobis(triph-
enylphosphine)palladium(II) (14 mg, 0.02 mmol), and triph-
enylphosphine (11 mg, 0.04 mmol). The flask is evacuated and
back-filled with argon five times, and dry dimethylformamide (3
mL) is then added. The resulting mixture is stirred at 100 °C for
ca. 20 h. After cooling to room temperature, the mixture is diluted
with dichloromethane (∼5 mL) and SiO2 (∼300 mg) is added.
Evaporation of the solvents under reduced pressure affords a crude
product dispersed on silica gel that is purified by column chroma-
tography on silica gel with use of progressively more polar 10:4:1
f 5:4:1 hexanes:dichloromethane:ethyl acetate (v/v/v) as the mobile
phase, yielding the pure tetramer 37 as a pale yellow solid (82 mg,
1
79%). Mp >210 °C dec; H NMR (500 MHz, CDCl3) δ 7.58-
7.56 (m, 4H), 7.52-7.50 (m, 4H), 7.46-7.44 (m, 4H), 7.43-7.41
(m, 4H), 7.13-7-07 (m, 16H), 6.41 (s, 2H), 6.18 (s, 2H), 6.09 (s,
2H), 6.01 (s, 2H), 4.44 (s, 6H); 13C NMR (125 MHz, CDCl3) δ
160.9, 152.7, 152.6, 150.3, 150.0, 147.8, 147.4, 144.1, 143.7, 143.5,
143.3, 136.4, 126.3, 126.2, 126.1, 125.9, 125.4, 125.3, 125.2, 124.6,
55.5, 50.5, 50.0, 49.8, 46.9; IR (KBr) 3043, 2951, 1569, 1459, 1379,
1299, 730; HR-MS (ESI) calcd for C74H46N8O2 [M + H]+
1079.3816, found 1079.3782.
(g) Sexipyridazine (38). In a septum-capped Schlenk flask are
placed the chloro methoxy dimer 34 (230 mg, 0.40 mmol), the
dichloro dimer 33a (58 mg, 0.10 mmol), activated zinc dust (235
mg, 3.6 mmol), trans-dichlorobis(triphenylphosphine)palladium-
(II) (42 mg, 0.06 mmol), and triphenylphosphine (32 mg, 0.12
mmol). The flask is evacuated and back-filled with argon five times,
J. Org. Chem, Vol. 72, No. 26, 2007 10179